Compounds > c 1311
Page last updated: 2024-09-03

c 1311 and Cancer of Colon

c 1311 has been researched along with Cancer of Colon in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brillowska-Dąbrowska, A; Konopa, J; Paradziej-Łukowicz, J; Peszyńska-Sularz, G; Skwarska, A1
Bozko, P; Hyzy, M; Konopa, J; Skladanowski, A1
Alami, N; Belanger, S; Grieshaber, CK; Juste, S; Leyland-Jones, B; Paterson, J1
Bibby, MC; Burger, AM; Double, JA; Konopa, J1
Bibby, MC; Burger, AM; Double, JA; Jenkins, TC1

Other Studies

5 other study(ies) available for c 1311 and Cancer of Colon

ArticleYear
Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
    Cancer biology & therapy, 2011, Oct-01, Volume: 12, Issue:7

    Topics: Aminoacridines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell-Free System; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Response Elements; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

2011
Antitumour imidazoacridone C-1311 induces cell death by mitotic catastrophe in human colon carcinoma cells.
    Biochemical pharmacology, 2005, Mar-01, Volume: 69, Issue:5

    Topics: Aminoacridines; Antineoplastic Agents; Apoptosis; Colonic Neoplasms; DNA Damage; DNA Fragmentation; G2 Phase; HT29 Cells; Humans; Mitosis

2005
Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5

    Topics: Aminoacridines; Animals; Antineoplastic Agents; Camptothecin; Capecitabine; Cell Line, Tumor; Cell Proliferation; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Fluorouracil; HT29 Cells; Humans; In Vitro Techniques; Irinotecan; Mice; Mice, Nude; Organoplatinum Compounds; Oxaliplatin; Paclitaxel

2007
Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.
    British journal of cancer, 1996, Volume: 74, Issue:9

    Topics: Adenocarcinoma; Aminoacridines; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; DNA, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasms, Experimental; Time Factors; Transplantation, Heterologous

1996
Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311.
    British journal of cancer, 1999, Volume: 81, Issue:2

    Topics: Acid Phosphatase; Aminoacridines; Antineoplastic Agents; Apoptosis; Cell Division; Cell Nucleus; Colonic Neoplasms; DNA; DNA Fragmentation; HT29 Cells; Humans; Microscopy, Fluorescence

1999